Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Clinical trial NCT00162136 · COMPLETED

Trial details

NCT number: NCT00162136
Sponsor: R-Pharm
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Malignancies

Start date: 2005-09-01
Primary completion: 2008-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.